Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Tata India Pharma & Healthcare Fund | Bajaj Finserv Consumption Fund | |
|---|---|---|
| Category | Sectoral / Thematic | Sectoral / Thematic |
| Plan | Regular | Regular |
| Fund house | Tata | Bajaj Finserv |
| NAV | ₹33.9323 | ₹9.5000 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 10.9 years | 2.0 years |
| Expense ratio | 2.4% | 2.9% |
| Stars | ★★★★★ | Not rated |
| Growth Score | 65.70 | — |
Returns
| Tata India Pharma & Healthcare Fund | Bajaj Finserv Consumption Fund | |
|---|---|---|
| 1 month | +9.73% | +6.84% |
| 3 months | +0.76% | −0.48% |
| 6 months | +6.88% | +9.40% |
| YTD | +12.33% | +0.92% |
| 1 year | +10.25% | −2.34% |
| 3 years (CAGR) | +17.02% | — |
| 5 years (CAGR) | +14.30% | — |
| 10 years (CAGR) | +14.17% | — |
| Since launch | +11.82% | −3.01% |
Risk
| Tata India Pharma & Healthcare Fund | Bajaj Finserv Consumption Fund | |
|---|---|---|
| Volatility | 15.7% | — |
| Downside volatility | 10.1% | — |
| Sharpe | 0.67 | — |
| Sortino | 1.04 | — |
| Calmar | 1.00 | — |
| Return / risk | 1.09 | — |
| Deepest fall | −21.94% | −22.94% |
| Days to recover | 624 | — |
| Below its high | −0.20% | −7.03% |
Against benchmark
| Tata India Pharma & Healthcare Fund | Bajaj Finserv Consumption Fund | |
|---|---|---|
| Alpha | −4.21% | — |
| Beta | 1.00 | — |
| R² | 90.2% | — |
| Up capture | 88.9% | — |
| Down capture | 105.4% | — |
| Tracking error | 4.9% | — |
| Information ratio | −0.87 | — |
| Treynor | 0.09 | — |
Consistency
| Tata India Pharma & Healthcare Fund | Bajaj Finserv Consumption Fund | |
|---|---|---|
| Best 1-year | +73.72% | +2.99% |
| Middle 1-year | +7.27% | −5.33% |
| Worst 1-year | −18.70% | −13.77% |
| 1-year periods with a loss | 33.4% | 91.6% |
| Middle 3-year | +19.29% | — |
| Positive months | 61.1% | — |
| Best day | +3.33% | +3.54% |
| Worst day | −3.10% | −3.25% |
| Worst 5% day | −1.35% | −1.63% |
| Positive days | 54.9% | 50.9% |
| NAVs a year | 247 | 247 |
SIP of ₹10,000 a month
| Tata India Pharma & Healthcare Fund | Bajaj Finserv Consumption Fund | |
|---|---|---|
| 5-year XIRR | +16.33% | — |
| 5-year value | ₹9,09,680 | — |
| 3-year XIRR | +11.67% | — |
| 1-year XIRR | +16.78% | +8.85% |
Holdings overlap i
Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.